ALK-POSITIVE
Clinical trials for ALK-POSITIVE explained in plain language.
Never miss a new study
Get alerted when new ALK-POSITIVE trials appear
Sign up with your email to follow new studies for ALK-POSITIVE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Drug combo aims to outsmart resistant lung cancer
Disease control OngoingThis early-phase trial tests the combination of two oral drugs, ceritinib and everolimus, in people with advanced solid tumors or a specific type of lung cancer (ALK-positive NSCLC) that has stopped responding to standard treatments. The main goal is to find a safe dose and look …
Matched conditions: ALK-POSITIVE
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
Lung cancer drug crizotinib tested as Post-Surgery shield
Disease control OngoingThis phase 3 trial tests whether the drug crizotinib can improve survival in people with early-stage non-small cell lung cancer that has a specific genetic change called ALK fusion. After surgery to remove the tumor, patients either take crizotinib pills or are simply observed. T…
Matched conditions: ALK-POSITIVE
Phase: PHASE3 • Sponsor: ECOG-ACRIN Cancer Research Group • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC